CATHAY BIOTECH (China) Today

688065
  

CNY 63.81  0.68  1.05%   

Market Performance
0 of 100
Odds Of Distress
Less than 28
CATHAY BIOTECH is trading at 63.81 as of the 29th of November 2022, a -1.05 percent decrease since the beginning of the trading day. The stock's open price was 64.49. CATHAY BIOTECH has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for CATHAY BIOTECH INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2020 and ending today, the 29th of November 2022. Click here to learn more.
Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. CATHAY BIOTECH operates under Chemicals classification in China and is traded on Shanghai Stock Exchange. It employs 2035 people. The company has 583.36 M outstanding shares. More on CATHAY BIOTECH INC

Moving together with CATHAY BIOTECH

+0.81002460GANFENG LITHIUM COPairCorr
+0.84605366JIANGXI HUNGPAI NEWPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

CATHAY BIOTECH Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CATHAY BIOTECH's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CATHAY BIOTECH or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CATHAY BIOTECH INC generated a negative expected return over the last 90 days
CATHAY BIOTECH INC has high historical volatility and very poor performance
About 75.0% of the company shares are owned by insiders or employees
Thematic Ideas
(view all).
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of CATHAY BIOTECH's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
CATHAY BIOTECH INC (688065) is traded on Shanghai Stock Exchange in China and employs 2,035 people. The company currently falls under 'Large-Cap' category with current market capitalization of 27.04 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CATHAY BIOTECH's market, we take the total number of its shares issued and multiply it by CATHAY BIOTECH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. CATHAY BIOTECH INC operates under Basic Materials sector and is part of Chemicals industry. The entity has 583.36 M outstanding shares. CATHAY BIOTECH INC has accumulated about 6.95 B in cash with 809.91 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.64.
Check CATHAY BIOTECH Probability Of Bankruptcy
Ownership
CATHAY BIOTECH holds a total of five hundred eighty-three million three hundred sixty thousand outstanding shares. CATHAY BIOTECH INC shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 75.25 percent of CATHAY BIOTECH INC outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how much assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check CATHAY Ownership Details

CATHAY Stock Price Odds Analysis

What are CATHAY BIOTECH's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of CATHAY BIOTECH jumping above the current price in 90 days from now is about 77.72%. The CATHAY BIOTECH INC probability density function shows the probability of CATHAY BIOTECH stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon CATHAY BIOTECH has a beta of 0.4731. This suggests as returns on the market go up, CATHAY BIOTECH average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CATHAY BIOTECH INC will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. CATHAY BIOTECH INC is significantly underperforming DOW.
  Odds Below 63.81HorizonTargetOdds Above 63.81
22.18%90 days
 63.81 
77.72%
Based on a normal probability distribution, the odds of CATHAY BIOTECH to move above the current price in 90 days from now is about 77.72 (This CATHAY BIOTECH INC probability density function shows the probability of CATHAY Stock to fall within a particular range of prices over 90 days) .

CATHAY BIOTECH INC Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. CATHAY BIOTECH market risk premium is the additional return an investor will receive from holding CATHAY BIOTECH long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CATHAY BIOTECH. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although CATHAY BIOTECH's alpha and beta are two of the key measurements used to evaluate CATHAY BIOTECH's performance over the market, the standard measures of volatility play an important role as well.

CATHAY Stock Against Markets

Picking the right benchmark for CATHAY BIOTECH stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CATHAY BIOTECH stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CATHAY BIOTECH is critical whether you are bullish or bearish towards CATHAY BIOTECH INC at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in CATHAY BIOTECH without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Invested in CATHAY BIOTECH INC?

The danger of trading CATHAY BIOTECH INC is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CATHAY BIOTECH is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CATHAY BIOTECH. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CATHAY BIOTECH INC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the CATHAY BIOTECH INC information on this page should be used as a complementary analysis to other CATHAY BIOTECH's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for CATHAY Stock analysis

When running CATHAY BIOTECH INC price analysis, check to measure CATHAY BIOTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CATHAY BIOTECH is operating at the current time. Most of CATHAY BIOTECH's value examination focuses on studying past and present price action to predict the probability of CATHAY BIOTECH's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CATHAY BIOTECH's price. Additionally, you may evaluate how the addition of CATHAY BIOTECH to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Please note, there is a significant difference between CATHAY BIOTECH's value and its price as these two are different measures arrived at by different means. Investors typically determine CATHAY BIOTECH value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CATHAY BIOTECH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.